WuXi XDC Cayman, Inc. (HK:2268)
:2268
Want to see HK:2268 full AI Analyst Report?
Comparison Results
WuXi XDC Cayman, Inc.
HK$54.80
HK$70.28B
48.72
55.71%
10 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$35.72
HK$135.98B
24.33
36.05%
11 Buy
1 Hold
0 Sell
Strong Buy
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$54.00
HK$38.92B
151.86
18.89%
7 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$51.29B
22.45
37.80%
7 Buy
0 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$122.90
HK$355.88B
16.25
93.74%
8 Buy
0 Hold
0 Sell
Strong Buy
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$73.80
HK$51.02B
23.82
49.96%
5 Buy
1 Hold
0 Sell
Strong Buy
Performance Comparison
HK:2268
WuXi XDC Cayman, Inc.
57.30
20.40
55.28%
HK:2269
Wuxi Biologics (Cayman)
32.72
8.87
37.19%
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
32.04
3.07
10.61%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
18.41
4.63
33.63%
HK:2359
WuXi AppTec Co., Ltd. Class H
130.00
63.46
95.36%
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
97.70
31.19
46.90%